Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research
Michelle Long Schoettler(Children's Healthcare of Atlanta), Sumithira Vasu(The Ohio State University), Paul A. Carpenter(Fred Hutch Cancer Center), Enric Carreras(Josep Carreras Leukaemia Research Institute), John Koreth(Otsuka (Japan)), Isabel Sánchez‐Ortega(European Society for Blood and Marrow Transplantation), Alok Srivastava(M.J.P. Rohilkhand University), N. Kroger(The Ohio State University), I. Moissev(First Pavlov State Medical University of St. Petersburg), Kristin Page(Medical College of Wisconsin), V.T. Ho(Dana-Farber Cancer Institute), Byung‐Sik Cho(The Korean Society of Blood and Marrow Transplantation), Christopher E. Dandoy(Cincinnati Children's Hospital Medical Center), Uday Popat(The University of Texas MD Anderson Cancer Center), Robert J. Soiffer(Dana-Farber Cancer Institute), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Per Ljungman(Karolinska University Hospital), BE. Shaw(Medical College of Wisconsin), Yoshiko Atsuta(The Japanese Data Center for Hematopoietic Cell Transplantation), Sonata Jodele(Cincinnati Children's Hospital Medical Center)
Cited by 130
Related Papers
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome
|Biology of Blood and Marrow Transplantation|2009|595
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
|New England Journal of Medicine|2016|595
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
|Journal of Clinical Oncology|2017|468
Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation
|Biology of Blood and Marrow Transplantation|2005|458